Fox Hill Wealth Management
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2016110
DEDHAM, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$312,443
+$33,356 QoQ
Shares Held
629
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,214
of 1,735 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fox Hill Wealth Management holds $312,443 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
629 | $312,443 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,443 | 629 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $279,087 | 625 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $283,350 | 625 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $254,174 | 649 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $304,071 | 683 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $328,223 | 677 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $273,030 | 678 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $322,300 | 693 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $313,104 | 668 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $287,172 | 687 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $273,430 | 672 | Shares | Sole | 2024-04-17 | |
| No filing history on record for this holder in this stock. | ||||||